Novel regimen for the treatment of juvenile myelomonocytic leukemia (JMML)

Leukemia Research

Volumn 28, Issue 2, 2004, Pages 167-170

  Kang, Hyoung Jin ^a   Shin, Hee Young ^b   Choi, Hyoung Soo ^b   Ahn, Hyo Seop ^b  

^a National Cancer Center   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Chemotherapy; Differentiation therapy; Juvenile myelomonocytic leukemia

Indexed keywords

CYTARABINE; ETOPOSIDE; ISOTRETINOIN; VINCRISTINE;

ARTICLE; BLAST CELL CRISIS; BLOOD; BONE MARROW CELL; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CELL MATURATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; INFANT; JUVENILE MYELOMONOCYTIC LEUKEMIA; MALE; NEUTROPENIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SALVAGE THERAPY; SPLEEN SIZE; STEM CELL TRANSPLANTATION; STOMATITIS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0345275996     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(03)00217-0     Document Type: Article

References (16)

1. Hasle H., Niemeyer C.M., Chessells J.M., Baumann I., Bennett J.M., Kerndrup G., et al. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia. 17:2003;277-282.
2. Niemeyer C.M., Arico M., Basso G., Biondi A., Cantu Rajnoldi A., Creutzig U., et al. Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases, European Working Group on myelodysplastic syndromes in childhood (EWOG-MDS). Blood. 89:1997;3534-3543.
3. Niemeyer C.M., Fenu S., Hasle H., Mann G., Stary J., van Wering E. Differentiating juvenile myelomonocytic leukemia from infectious disease. Blood. 91:1998;365-367.
4. Arico M., Biondi A., Pui C.-H. Juvenile myelomonocytic leukemia. Blood. 90:1997;479-488.
5. Matthes-Martin S., Mann G., Peters C., Lion T., Fritsch G., Haas O.A., et al. Allogeneic bone marrow transplantation for juvenile myelomonocytic leukaemia: a single centre experience and review of the literature. Bone marrow trans. 26:2000;377-382.
6. Lutz P., Zix-Kieffer I., Souillet G., Bertrand Y., Dhooge C., Rubie C., et al. Juvenile myelomonocytic leukemia: analyses of treatment results in the EORTC Children's Leukemia Cooperative Group (CLCG). Bone marrow trans. 18:1996;1111-1116.
7. Castleberry R.P., Emanuel P.D., Zuckerman K.S., Cohn S., Strauss L., Byrd R.L., et al. A pilot study of isotretinoin in the treatment of juvenile chronic myelogenous leukemia. N. Engl. J. Med. 331:1994;1680-1684.
8. Vardiman J.W., Harris N.L., Brunning R.D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 100:2002;2292-2302.
9. Locatelli F., Niemeyer C., Angelucci E., Bender-Gotze C., Burdach S., Ebell W., et al. Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on myelodysplastic syndrome in childhood. J. Clin. Oncol. 15:1997;566-573.
10. Smith F.O., King R., Nelson G., Wagner J.E., Robertson K.A., Sanders J.E., et al. The National Marrow Donor Program: unrelated donor bone marrow transplantation for children with juvenile myelomonocytic leukaemia. Br. J. Haematol. 116:2002;716-724.
11. Manabe A., Okamura J., Yumura-Yagi K., Akiyama Y., Sako M., Uchiyama H., et al. MDS committee of the Japanese Society of Pediatric Hematology: allogeneic hematopoietic stem cell transplantation for 27 children with juvenile myelomonocytic leukemia diagnosed based on the criteria of the International JMML Working Group. Leukemia. 16:2002;645-649.
12. Sauter C., Fehr J., Frick P., Gmuer J., Honegger H., Martz G. Acute myelogenous leukemia: successful treatment of relapse with cytosine arabinoside, VP 16-213, vincristine and vinblastine (A-triple-V). Eur. J. Cancer Clin. Oncol. 18:1982;733-737.
13. Wisch J.S., Griffin J.D., Kufe D.W. Response of preleukemic syndromes to continuous infusion of low-dose cytarabine. N. Engl. J. Med. 309:1983;1599-1602.
14. Cheson B.D., Jasperse D.M., Simon R., Friedman M.A. A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes. J. Clin. Oncol. 4:1986;1857-1864.
15. Pui C.H., Arico M. Isotretinoin for juvenile chronic myelogenous leukemia. N. Engl. J. Med. 332:1995;1520-1521.
16. Ohnuma K., Isoyama K., Ikuta K., Toyoda Y., Nakamura J., Nakajima F., et al. Cord blood transplantation from HLA-mismatched unrelated donors as a treatment for children with haematological malignancies. Br. J. Haematol. 112:2001;981-987.